Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension

• Authors: Yvonne Commodore-Mensah, Johns Hopkins School of Nursing; Fleetwood Loustalot, Centers for Disease Control and Prevention, Atlanta; Cheryl D Himmelfarb, Johns Hopkins School of Nursing; Patrice Desvigne-Nickens, National Heart, Lung, and Blood Institute, Bethesda; Vandana Sachdev, National Heart, Lung, and Blood Institute, Bethesda; Kirsten Bibbins-Domingo, University of California San Francisco; Steven B Clauser, Patient Centered Outcomes Research Institute; Deborah J Cohen, Oregon Health & Science University; Brent M Egan, American Medical Association; Mark A Fendrick, University of Michigan; Keith C Ferdinand, Tulane University; Cliff Goodman, The Lewin Group, Falls Church; Garth N Graham, Google Health and Youtube, Playa Vista; Marc G Jaffe, Kaiser Permanente San Francisco Med Ctr; Harlan M Krumholz, Yale School of Medicine; Philip D Levy, Wayne State University; Glen P Mays, Colorado School of Public Health, Aurora; Robert McNellis, Agency for Healthcare Research and Quality; Paul Muntner, University of Alabama Birmingham; Gbenga Ogedegbe, New York University; Richard Milani, Ochsner Health System, New Orleans; Linnea A Polgreen, University of Iowa; Lonny Reisman, HealthReveal, Glen Head; Eduardo J Sanchez, American Heart Association, Dallas; Laurence Sperling, Emory University; Hilary K Wall, Centers for Disease Control and Prevention, Atlanta; Lori Whitten, Synergy Enterprises Inc; Jackson T Wright, University Hospitals of Cleveland; Janet S Wright, Centers for Disease Control and Prevention, Atlanta; Lawrence J Fine, NHLBI
• Journal Title: AMERICAN JOURNAL OF HYPERTENSION
• Volume: Volume 35, Number 3
• Publisher: OXFORD UNIV PRESS | 2022-03-08, Pages 232-243
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1093/ajh/hpab182
• Subjects: Health Sciences, Epidemiology; Biology, Biostatistics; Health Sciences, Medicine and Surgery; Health Sciences, Pharmacy
• Keywords: Science & Technology; Life Sciences & Biomedicine; Peripheral Vascular Disease; Cardiovascular System & Cardiology; blood pressure; cardiovascular disease; hypertension; prevention; screening; TEAM-BASED CARE; AGED 60 YEARS; PRESSURE CONTROL; CLINICAL-PRACTICE; AMERICAN-COLLEGE; HEALTH-CARE; MANAGEMENT; ADULTS; IMPACT; DISPARITIES

Abstract

Hypertension treatment and control prevent more cardiovascular events than management of other modifiable risk factors. Although the age-adjusted proportion of US adults with controlled blood pressure (BP) defined as <140/90 mm Hg, improved from 31.8% in 1999-2000 to 48.5% in 2007-2008, it remained stable through 2013-2014 and declined to 43.7% in 2017-2018. To address the rapid decline in hypertension control, the National Heart, Lung, and Blood Institute and the Division for Heart Disease and Stroke Prevention of the Centers for Disease Control and Prevention convened a virtual workshop with multidisciplinary national experts. Also, the group sought to identify opportunities to reverse the adverse trend and further improve hypertension control. The workshop immediately preceded the Surgeon General's Call to Action to Control Hypertension, which recognized a stagnation in progress with hypertension control. The presentations and discussions included potential reasons for the decline and challenges in hypertension control, possible "big ideas,"and multisector approaches that could reverse the current trend while addressing knowledge gaps and research priorities. The broad set of "big ideas"was comprised of various activities that may improve hypertension control, including: interventions to engage patients, promotion of self-measured BP monitoring with clinical support, supporting team-based care, implementing telehealth, enhancing community-clinical linkages, advancing precision population health, developing tailored public health messaging, simplifying hypertension treatment, using process and outcomes quality metrics to foster accountability and efficiency, improving access to high-quality health care, addressing social determinants of health, supporting cardiovascular public health and research, and lowering financial barriers to hypertension control.